SANODERM LIMITED

Active Sheffield

Research and experimental development on biotechnology

1 employees website.com
Research and experimental development on biotechnology
S

SANODERM LIMITED

Research and experimental development on biotechnology

Founded 7 Sept 2020 Active Sheffield, United Kingdom 1 employees website.com
Research and experimental development on biotechnology

Previous Company Names

BEXS CAPITAL SPECIAL OPPORTUNITIES LIMITED 7 Sept 2020 — 6 Sept 2024
Accounts Submitted 31 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 18 Sept 2025 Next due 20 Sept 2026 4 months remaining
Net assets £929K £929K 2024 year on year
Total assets £2M £3M 2024 year on year
Total Liabilities £866K £4M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Irwin Mitchell Llp Riverside East 2 Millsands Sheffield South Yorkshire S3 8DT United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for SANODERM LIMITED (12860581), an active company based in Sheffield, United Kingdom. Incorporated 7 Sept 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

N/A

Net Assets

£928.91k

Increased by £928.81k (+928809%)

Total Liabilities

£866.03k

Decreased by £4.08M (-83%)

Turnover

N/A

Employees

1

Debt Ratio

48%

Decreased by 52 (-52%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 213,605 Shares £4.95m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
7 Sept 2024106,460£2.90m£27.25
7 Sept 202449,100£1.34m£27.25
7 Sept 20241,550£42k£27.25
7 Sept 2024620£17k£27.25
7 Sept 2024460£13k£27.25

Officers

Officers

2 active
Status
Inclin Investments LlcCorporate-directorUnknownUnknown7 Sept 2024Active
Marc David ShirmanDirectorBritishEngland467 Sept 2020Active

Shareholders

Shareholders (10)

Inclin Investments Llc
49.6%
106,460
Bexs Capital Management Limited
15.4%
33,075

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Marc David Shirman

British

Active
Notified 5 Jul 2022
Residence England
DOB March 1980
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Inclin Investments Llc

Unknown

Active
Notified 7 Sept 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Bexs Capital Limited

Ceased 5 Jul 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
18 Sept 2025Confirmation StatementConfirmation statement made on 6 Sept 2025 with updates
17 Sept 2025Persons With Significant ControlInclin Investments Llc notified as a person with significant control
17 Sept 2025Persons With Significant ControlCessation of Marc David Shirman as a person with significant control on 6 Sept 2024
3 Apr 2025OfficersAppointment of Inclin Investments Llc as director on 7 Sept 2024
31 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

18 Sept 2025 Confirmation Statement

Confirmation statement made on 6 Sept 2025 with updates

17 Sept 2025 Persons With Significant Control

Inclin Investments Llc notified as a person with significant control

17 Sept 2025 Persons With Significant Control

Cessation of Marc David Shirman as a person with significant control on 6 Sept 2024

3 Apr 2025 Officers

Appointment of Inclin Investments Llc as director on 7 Sept 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

4 months ago on 31 Dec 2025

Confirmation statement made on 6 Sept 2025 with updates

7 months ago on 18 Sept 2025

Inclin Investments Llc notified as a person with significant control

7 months ago on 17 Sept 2025

Cessation of Marc David Shirman as a person with significant control on 6 Sept 2024

7 months ago on 17 Sept 2025

Appointment of Inclin Investments Llc as director on 7 Sept 2024

1 years ago on 3 Apr 2025